Radiofrequency ablation of T1 lung carcinoma: Comparison of outcomes for first primary, metachronous, and synchronous lung tumors

Journal of Vascular and Interventional Radiology

Volumn 25, Issue 7, 2014, Pages 989-996

  Ridge, Carole A ^a   Silk, Mikhail ^b   Petre, Elena N ^c   Erinjeri, Joseph P ^c   Alago, William ^c   Downey, Robert J ^c   Sofocleous, Constantinos T ^c   Thornton, Raymond H ^c   Solomon, Stephen B ^c  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER PATIENT; CANCER STAGING; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIOFREQUENCY ABLATION; RADIOFREQUENCY ABLATION DEVICE; TREATMENT OUTCOME; TUMOR VOLUME; ADENOCARCINOMA; CARCINOMA, NON-SMALL-CELL LUNG; CATHETER ABLATION; DISEASE COURSE; DISEASE FREE SURVIVAL; KAPLAN MEIER METHOD; LUNG NEOPLASMS; MIDDLE AGED; MORTALITY; MULTIDETECTOR COMPUTED TOMOGRAPHY; MULTIMODAL IMAGING; MULTIPLE CANCER; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; RETROSPECTIVE STUDY; RISK FACTOR; SECOND CANCER; SQUAMOUS CELL CARCINOMA; TIME; VERY ELDERLY;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CATHETER ABLATION; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; MULTIMODAL IMAGING; NEOPLASM STAGING; NEOPLASMS, MULTIPLE PRIMARY; NEOPLASMS, SECOND PRIMARY; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84903273541     PISSN: 10510443     EISSN: 15357732     Source Type: Journal    
DOI: 10.1016/j.jvir.2014.02.021     Document Type: Article

References (39)

1. J. Donington, M. Ferguson, and P. Mazzone et al. Thoracic Oncology Network of American College of Chest Physicians; Workforce on Evidence-Based Surgery of Society of Thoracic Surgeons. American College of Chest Physicians and Society of Thoracic Surgeons consensus statement for evaluation and management for high-risk patients with stage I non-small cell lung cancer Chest 142 2012 1620 1635
2. R.J. Keenan, R.J. Landreneau, and R.H. Maley Jr et al. Segmental resection spares pulmonary function in patients with stage I lung cancer Ann Thorac Surg 78 2004 228 233
3. Howlader N, Noone AM, Krapcho M, et al (eds). SEER Cancer Statistics Review, 1975-2010. National Cancer Institute. Available at: http://seer.cancer. gov/csr/1975-2010/. Based on November 2012 SEER data submission, posted to the SEER web site April 2013.
4. F.C. Detterbeck, S.Z. Lewis, R. Diekemper, D. Addrizzo-Harris, and W.M. Alberts Executive Summary: Diagnosis and management of lung cancer, 3rd edition: American College of Chest Physicians evidence-based clinical practice guidelines Chest 143 2013 7S 37S
5. B.E. Johnson, P. Cortazar, and J.P. Chute Second lung cancers in patients successfully treated for lung cancer Semin Oncol 24 1997 492 499
6. N. Martini, and M.R. Melamed Multiple primary lung cancers J Thorac Cardiovasc Surg 70 1975 606 612
7. M. Hamaji, M.S. Allen, and S.D. Cassivi et al. Surgical treatment of metachronous second primary lung cancer after complete resection of non-small cell lung cancer J Thorac Cardiovasc Surg 145 2013 683 690
8. T. Naruke, T. Goya, R. Tsuchiya, and K. Suemasu Prognosis and survival in resected lung carcinoma based on the new international staging system J Thorac Cardiovasc Surg 96 1988 440 447
9. S.C. Rose, D.E. Dupuy, and D.A. Gervais et al. Technology Assessment Committee of the Society of Interventional Radiology. Research reporting standards for percutaneous thermal ablation of lung neoplasms J Vasc Interv Radiol 20 2009 S474 S485
10. E.M. Anderson, W.R. Lees, and A.R. Gillams Early indicators of treatment success after percutaneous radiofrequency of pulmonary tumors Cardiovasc Intervent Radiol 32 2009 478 483
11. F.J. Wolf, D.J. Grand, J.T. Machan, T.A. Dipetrillo, W.W. Mayo-Smith, and D.E. Dupuy Microwave ablation of lung malignancies: effectiveness, CT findings, and safety in 50 patients Radiology 247 2008 871 879
12. R. Lencioni, L. Crocetti, and R. Cioni et al. Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study) Lancet Oncol 9 2008 621 628
13. H. Schoellnast, A. Deodhar, and M. Hsu et al. Recurrent non-small cell lung cancer: evaluation of CT-guided radiofrequency ablation as salvage therapy Acta Radiol 53 2012 893 899
14. H.C. Fernando, A. De Hoyos, and R.J. Landreneau et al. Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates J Thorac Cardiovasc Surg 129 2005 639 644
15. C.T. Sofocleous, B. May, and E.N. Petre et al. Pulmonary thermal ablation in patients with prior pneumonectomy AJR Am J Roentgenol 196 2011 W606 W612
16. A. Zemlyak, W.H. Moore, and T.V. Bilfinger Comparison of survival after sublobar resections and ablative therapies for stage I non-small cell lung cancer J Am Coll Surg 211 2010 68 72
17. A. Pennathur, J.D. Luketich, and G. Abbas et al. Radiofrequency ablation for the treatment of stage I non-small cell lung cancer in high-risk patients J Thorac Cardiovasc Surg 134 2007 857 864
18. T. Hiraki, H. Gobara, and T. Iishi et al. Percutaneous radiofrequency ablation for clinical stage I non-small cell lung cancer: results in 20 nonsurgical candidates J Thorac Cardiovasc Surg 134 2007 1306 1312
19. M. Hsie, S. Morbidini-Gaffney, L.J. Kohman, E. Dexter, E.M. Scalzetti, and J.A. Bogart Definitive treatment of poor-risk patients with stage I lung cancer: a single institution experience J Thorac Oncol 4 2009 69 73
20. M. Lanuti, A. Sharma, and S.R. Digumarthy et al. Radiofrequency ablation for treatment of medically inoperable stage I non-small cell lung cancer J Thorac Cardiovasc Surg 137 2009 160 166
21. T. Hiraki, H. Gobara, and H. Mimura et al. Radiofrequency ablation of lung cancer at Okayama University Hospital: a review of 10 years of experience Acta Med Okayama 65 2011 287 297
22. M.C. Ambrogi, O. Fanucchi, and R. Cioni et al. Long-term results of radiofrequency ablation treatment of stage I non-small cell lung cancer: a prospective intention-to-treat study J Thorac Oncol 6 2011 2044 2051
23. C.J. Simon, D.E. Dupuy, and T.A. DiPetrillo et al. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients Radiology 243 2007 268 275
24. D.E. Dupuy, H. Fernando, and S. Hillman et al. Radiofrequency ablation of stage 1A NSCLC in medically inoperable patients: results from ACOSOG Z4033 (Alliance), an NCI funded multicenter trial Chest 144 2013 86A
25. H. Liu, and K. Steinke High-powered percutaneous microwave ablation of stage I medically inoperable non-small cell lung cancer: a preliminary study J Med Imaging Radiat Oncol 57 2013 466 474
26. Y. Yamauchi, Y. Izumi, and K. Hashimoto et al. Percutaneous cryoablation for the treatment of medically inoperable stage I non-small cell lung cancer PLoS One 7 2012 e33223
27. T. Ishigaki, T. Yoshimasu, and S. Oura et al. Surgical treatment for metachronous second primary lung cancer after radical resection of primary lung cancer Ann Thorac Cardiovasc Surg 19 2013 341 344
28. S.W. Kwan, K.E. Mortell, A.D. Talenfeld, and M.C. Brunner Thermal ablation matches sublobar resection outcomes in older patients with early-stage non-small cell lung cancer J Vasc Interv Radiol 25 2014 1 9
29. M. Taremi, A. Hope, and M. Dahele et al. Stereotactic body radiotherapy for medically inoperable lung cancer: prospective, single-center study of 108 consecutive patients Int J Radiat Oncol Biol Phys 82 2012 967 973
30. J. Varlotto, A. Fakiris, and J. Flickinger et al. Matched-pair and propensity score comparisons of outcomes of patients with clinical stage I non-small cell lung cancer treated with resection or stereotactic radiosurgery Cancer 119 2013 2683 2691
31. A.J. Fakiris, R.C. McGarry, and C.T. Yiannoutsos et al. Stereotactic body radiation therapy for early-stage non-small cell lung carcinoma: four year results of a prospective phase II study Int J Radiat Oncol Biol Phys 75 2009 677 682
32. R. Timmerman, R. Paulus, and J. Galvin et al. Stereotactic body radiation therapy for inoperable early stage lung cancer JAMA 303 2010 1070 1076
33. T.D. Crabtree, C.E. Denlinger, and B.F. Meyers et al. Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer J Thorac Cardiovasc Surg 140 2010 377 386
34. S.S. Jeppesen, T. Schytte, H.R. Jensen, C. Brink, and O. Hansen Stereotactic body radiation therapy versus conventional radiation therapy in patients with early stage non-small cell lung cancer: an updated retrospective study on local failure and survival rates Acta Oncol 52 2013 1552 1558
35. C. Matthiesen, J.S. Thompson, T. De La Fuente Herman, S. Ahmad, and T. Herman Use of stereotactic body radiation therapy for medically inoperable multiple primary lung cancer J Med Imaging Radiat Oncol 56 2012 561 566
36. D.E. Dupuy Treatment of medically inoperable non-small-cell lung cancer with stereotactic body radiation therapy versus image-guided tumor ablation: can interventional radiology compete? J Vasc Interv Radiol 24 2013 1139 1145
37. H. Lee, G.Y. Jin, and Y.M. Han et al. Comparison of survival rate in primary non-small-cell lung cancer among elderly patients treated with radiofrequency ablation, surgery, or chemotherapy Cardiovasc Intervent Radiol 35 2012 343 350
38. M.S. Allen, G.E. Darling, T.T.V. Pechet the ACOSOG Z0030 Study Group Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 Trial Ann Thorac Surg 81 2006 1013 1019
39. C.T. Sofocleous, S.K. Garg, and P. Cohen et al. Ki 67 is an independent predictive biomarker of cancer specific and local recurrence-free survival after lung tumor ablation Ann Surg Oncol 20 2013 S676 S683